II
HCAT icon

Inspire Investing’s Health Catalyst HCAT Stock Holding History

Inspire Investing’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-103,494
Closed -$390K – 895
2025
Q2 		$390K Buy
103,494
+27,582
+36% +$109K 0.04% 516
2025
Q1 		$344K Buy
75,912
+19,533
+35% +$103K 0.04% 529
2024
Q4 		$399K Buy
56,379
+7,019
+14% +$55.9K 0.04% 704
2024
Q3 		$402K Sell
49,360
-5,574
-10% -$40.3K 0.04% 748
2024
Q2 		$351K Buy
54,934
+7,737
+16% +$49.7K 0.04% 616
2024
Q1 		$355K Buy
+47,197
New +$431K 0.04% 750

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Inspire Investing's HCAT Position: Q3 2025 in Review

Inspire Investing sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 103,494 shares — an estimated $390K sold.

Inspire Investing first reported a position in HCAT in Q1 2024 and held it in 6 quarters. The position peaked at $402K in Q3 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Inspire Investing reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Inspire Investing sold 103,494 Health Catalyst shares in Q3 2025, an estimated $390K.
  • Inspire Investing first reported a position in Health Catalyst in Q1 2024 and held it in 6 quarters.
  • Inspire Investing's Health Catalyst position peaked at $402K in Q3 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Inspire Investing's 13F filing for Q3 2025, filed 15 Oct 2025.